At a recent conference of professional hockey trainers, ZetrOZ Systems, a leading innovator and inventor of sustained acoustic medicine (sam®) for soft tissue injury healing, presented results of studies indicating the medical device is highly effective at treating the types of injuries hockey players frequently experience.
TRUMBULL, Conn., August 17, 2022 (Newswire.com) - ZetrOZ founder and CEO George Lewis, Ph.D., spoke at the annual PHATS (Professional Hockey Athletic Trainers Society) SPHEM (Society of Professional Hockey Equipment Managers) 2022 Conference, at the JW Marriott Marco Island Beach Resort in late June.
Speaking to more than 100 professional athletic trainers and equipment managers, Lewis spoke on the use of sam® for common soft tissue injuries, clinical research conducted on sam®, and actual results from real-world outcomes.
Research indicates that hockey players are at particular risk for low-back injuries, due to the flexed (forward) posture of skating and the frequent hyperextension (backward) stress; soft-tissue injuries, including groin and hip flexor strains, due to the mechanics of the skating stride; and injuries to the medial collateral ligament of the knee because of leg position while skating.
Lewis' lecture presented a recent clinical study examining the efficacy of sam® on soft-tissue injuries in patients who failed to respond to traditional RICE (rest, ice, compression, elevation) therapies. Findings showed that:
- 95% of patients were able to apply and execute sam® treatment;
- 93% of patients thought sam® was very easy to use;
- 87% of participants experienced an improvement in function and quality of life;
- 55% were able to return to activity immediately post-treatment;
- and patients saw a 20% reduction in blood lactate and an improvement in joint function from between 27% to 87%.
"We're finding that it takes more than RICE to get back on the ice. sam® is a non-invasive, non-narcotic alternative to pain and the results speak for themselves," Lewis said. "Sustained acoustic medicine is well-suited for the type of soft tissue and musculoskeletal injuries commonly sustained by hockey players."
"The trainers and managers were particularly responsive to the device's ease of use and the rate at which athletes could return to normal activity after treatment," Lewis said.
The ZetrOZ team also met with members of the Connecticut Whale, a professional women's ice hockey team based in Danbury, Connecticut, and ZetrOZ sponsoree, to discuss the latest findings and research on sam® for musculoskeletal injuries.
ZetrOZ Systems is a Platinum Sponsor of the PHATS/SPHEM 2022 Conference. PHATS/SPHEM boasts over 600 members, representing more than 100 professional, NCAA, and Canadian Junior League teams throughout North America and Europe.
To learn more about ZetrOZ Systems and its innovative health solutions, visit www.zetroz.com.
About ZetrOZ Systems
ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the southern coastal region of Connecticut. The organization also has manufacturing facilities across the United States. ZetrOZ Systems produces UltrOZ®, sam®Sport, and sam®Pro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis. Learn more at zetroz.com and samrecover.com.
Source: ZetrOZ Systems